Leveraging the Healing Power in Human Blood to Treat Disease

APstem is developing a first-in-class patented cell therapy technology that utilizes a novel proprietary class of stem cells called Adult High Plasticity Stem Cells (AHPSC), to treat serious diseases that have long impacted human health.

AHPSCs are derived from human donor blood and possess high regenerative ability and safety. Their unique high immunocompatibility enables allogeneic clinical applications.

The development of AHPSCs addresses key issues and barriers in current stem cell therapies. AHPSCs unique properties include:

• Treatment of a wide range of diseases

• Excellent safety profile

• Low cost, efficient manufacturing from healthy donors.